Literature DB >> 20226523

Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy.

David Belada, Lukás Smolej, Pavla Stepánková, Pavlína Králícková, Tomás Freiberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20226523     DOI： 10.1016/j.leukres.2010.01.024

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  4 in total

Review 1.  Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.

Authors:  Attila Kumánovics; Sherrie L Perkins; Heather Gilbert; Melissa H Cessna; Nancy H Augustine; Harry R Hill
Journal:  J Clin Immunol       Date:  2010-09-22       Impact factor: 8.317

2.  Diffuse Large B-Cell Lymphoma and Job's Syndrome: A Case Report.

Authors:  Rahmat Cahyanur; Sari Rahmawati
Journal:  Maedica (Bucur)       Date:  2020-06

3.  The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside.

Authors:  Efren L Rael; Robert T Marshall; Jonathan J McClain
Journal:  World Allergy Organ J       Date:  2012-07       Impact factor: 4.084

4.  [Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: a case report and literature review].

Authors:  M Zhang; W Zhang; Y Zhang; Y Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.